American Journal of Clinical Pathology · 2010 · 15 citations · 32 references
MedicineOncologyPathologyCervical DiseaseMolecular PathologyMolecular VirologyCervical BiopsyCervical CancerCervical CytologyCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyCervical Lesion ClassificationCervical Squamous LesionsHigh-risk Human Papillomavirus TypesHpv BiomarkersHuman Papillomavirus StatusImmunohistochemical BiomarkersImmunohistochemical MarkersNeutrophil Gelatinase-associated Lipocalin
Our objective was to assess whether neutrophil gelatinase-associated lipocalin (NGAL)/lipocalin 2 (LCN2) expression in cervical human papillomavirus (HPV) lesions has implications on the outcome of HPV infections or disease progression. Cervical biopsy specimens from 225 women in the Latin American Screening study were analyzed for NGAL/LCN2 expression using immunohistochemical analysis, to assess associations with cervical intraepithelial neoplasia (CIN) grade, high-risk HPV, and in predicting outcomes of high-risk (HR)-HPV infections. Expression of NGAL/LCN2 increased with lesion grade (odds ratio [OR], 3.86; 95% confidence interval [CI], 1.53-9.71; P = .001). Up-regulation was also related to HR-HPV detection (OR, 2.21; 95% CI, 1.15-4.24; P = .016) and showed a linear relationship to HR-HPV load (P = .002). NGAL/LCN2 expression was of no value in predicting the outcomes of HR-HPV infections or the surrogate end points (incident CIN 1+ and CIN 2+) of progressive disease. Because the SV40 large T antigen is a powerful up-regulator of this lipocalin, up-regulation of NGAL/LCN2 in CIN is probably induced by HR-HPV E6 oncoprotein, most likely by eliminating its normal transcription repression exerted by wild-type p53.
32
Gm Clifford, Silvano Gallus, Rolando Herrero et al. · The Lancet · 2005 · 1.1K citations · Full text
Medicine, Gynecology, Oncology +16
Yan Li, Niels Borregaard, Lars Kjeldsen et al. · Journal of Biological Chemistry · 2001 · 681 citations · Full text
Cecilia A. Fernández, Yan Li, Gwendolyn W. Louis et al. · Clinical Cancer Research · 2005 · 286 citations · Full text